What should you know about new immunotherapy for lung cancer?

Immunotherapy, also called checkpoint inhibitor therapy, changes signals that can stop immune cells from responding to a tumour. It may be offered alone, alongside chemotherapy, or after another treatment, depending on the cancer’s features and treatment goal. A medicine described as new may be newly approved, newly available locally, or being used in a different combination; your oncology team can explain what is relevant to your diagnosis.

Treatment is usually given in planned cycles through a vein, with assessments between doses. The immune response can affect healthy organs as well as cancer cells. Possible problems include inflammation of the skin, bowel, lungs, liver, thyroid or other hormone-producing glands. These effects are often manageable when recognised early, but they should not be ignored.

Bring a current list of medicines, supplements, allergies and previous cancer treatments. Ask whether biomarker testing, scans or blood tests are needed before treatment, and keep a record of each dose and any new symptom. Do not start steroids, immune medicines or supplements without checking, because they may affect the treatment plan.

During treatment, mention changes even if they seem mild: a new cough, loose stools, rash, unusual tiredness, headaches, dizziness, changes in weight, or altered urination. Your team may pause treatment, investigate the cause, or prescribe treatment for inflammation. Vaccines, dental work and planned travel should also be discussed before the next cycle.

Contact your oncology team promptly for worsening breathlessness, a new or persistent cough, chest pain, severe diarrhoea, blood in the stool, yellowing of the eyes, a widespread blistering rash, confusion, severe weakness, or a sudden change in vision. These symptoms can signal immune-related inflammation or another urgent problem.

Seek emergency help for severe breathing difficulty, fainting, new one-sided weakness, or sudden confusion. Keep your treatment contact details available and tell any emergency clinician that you are receiving immunotherapy.

Which immunotherapy medicine or combination is being considered, and what feature of my lung cancer supports it? What is the aim of treatment? How will response and side effects be checked? Which symptoms should make me call the oncology team the same day?